1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Genethon: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study to Assess Safety, Efficacy and Pharmacodynamic Profile of GNT0004 in Duchenne Muscular Dystrophy GNT0004 (1x10e13 vg/kg), GNT0004 (3x10e13 vg/kg), Placebo - Duchene Muscular Dystrophy | Phase 2 / Phase 3 | Recruiting | Genethon | 77 | 2021-03-01 | 2026-10-13 |
Belgium (1) · France (1) · Spain (1) · United Kingdom (1)
2023 (1)